Zopiclone was developed and first introduced in 1986 by Rhône-Poulenc S.A., now part of Sanofi-Aventis, the main worldwide manufacturer.
Zopiclone, as traditionally sold worldwide, is a racemic mixture of two stereoisomers, only one of which is active [REF].